Our overall objective is to conduct a safety study with inhaled ciclesonide to evaluate known glucocorticoids (sGC)-related acute and intermediate toxic effects while measuring for the first time in neonates its systemic absorption and potential bioactivity (i.e. activation of primary target, the GR, in blood cells).
Bronchopulmonary Dysplasia
Our overall objective is to conduct a safety study with inhaled ciclesonide to evaluate known glucocorticoids (sGC)-related acute and intermediate toxic effects while measuring for the first time in neonates its systemic absorption and potential bioactivity (i.e. activation of primary target, the GR, in blood cells).
Inhaled Ciclesonide Study in Preterm Infants
-
Children's Mercy Kansas City, Kansas City, Missouri, United States, 64108
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
8 Days to 28 Days
ALL
No
Children's Mercy Hospital Kansas City,
Venkatesh Sampath, MD, PRINCIPAL_INVESTIGATOR, Children's Mercy Hospital Kansas City
Venkatesh Sampath, MD, PRINCIPAL_INVESTIGATOR, Physician-Scientist
2026-08-31